Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Journal of Virology|May 16, 2014
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challengeFrancisco Miguel Cardoso, Lorena Itatí Ibañez, Silvie Van den Hoecke, et al.
Molecular & Cellular Proteomics : MCP|August 4, 2016
Phosphoproteomics to Characterize Host Response During Influenza A Virus Infection of Human MacrophagesSandra Söderholm, Denis E Kainov, Tiina Öhman, et al.
ACS Nano|February 7, 2012
Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infectionBruno G De Geest, Monique A Willart, Hamida Hammad, et al.
Journal of Virology|January 23, 2015
Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibodyKi Joon Cho, Bert Schepens, Jong Hyeon Seok, et al.
Plos Pathogens|January 28, 2016
A20 Deficiency in Lung Epithelial Cells Protects against Influenza A Virus InfectionJonathan Maelfait, Kenny Roose, Lars Vereecke, et al.
Cellular Signalling|April 20, 2004
Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencingTibor Vántus, Didier Vertommen, Xavier Saelens, et al.
Bioconjugate Chemistry|November 28, 2017
Transiently Thermoresponsive Acetal Polymers for Safe and Effective Administration of Amphotericin B as a Vaccine AdjuvantSimon Van Herck, Lien Van Hoecke, Benoit Louage, et al.
Nature Communications|February 15, 2017
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Science Translational Medicine|October 23, 2024
Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosaJozefien Declercq, Sarah Gerlo, Sharon Van Nevel, et al.
Antiviral Research|January 8, 2016
Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabineSandra Söderholm, Maria Anastasina, Mohammad Majharul Islam, et al.
Pageof 18